Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · F-1

Pulsenmore Ltd.

PLSMNASDAQEQUITYCurrent

SEC Filing

Filed Jul 2, 2026Accepted Jul 2, 2026, 4:05 PM EDTCIK 2064764Accession 0001493152-26-031872
Share

Company context

We are an emerging medical device company focused on research, development, manufacture, marketing, and sale of innovative, non-invasive portable ultrasound solutions that provide significant healthcare benefits by utilizing next-generation technology for home use. We currently have two primary products, the Pulsenmore ES and the Pulsenmore FC, and an additional third portable ultrasound solution that is in earlier developmental stages, the Pulsenmore MC. We collectively refer to our products as the “Pulsenmore Products”. The Pulsenmore Products open the door to a new market in the field of ultrasound - performing home scans in gynecology as well as in various other fields such as pulmonary, cardiology, and urology.

Current securities

Recent company filings

  1. 6-K filingSep 17, 2026
  2. 6-K filingSep 8, 2026
  3. EFFECT filingSep 1, 2026
  4. POS AM filingAug 31, 2026
  5. S-8 filingAug 31, 2026

As-filed source

Primary evidence